Humacyte, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -66.52M-85.54M-88.17M-101.18M-119.57M
Depreciation and Depletion 6.30M6.20M6.20M5.70M5.10M
Share-based Compensation 4.69M10.15M6.18M6.83M6.14M
Gains from Investment Securities 1.50M-55.77M-75.77M10.02M33.05M
Cash from Operations -55.60M-81.20M-71.13M-73.31M-98.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.06M2.06M2.06M2.06M2.09M
Depreciation & Amortization (CF) 6.30M6.20M6.20M5.70M5.10M
Change in Working Capital
Change in Receivables -0.49M0.06M-0.14M-0.03M
Change in Account Payables -0.89M-0.20M-0.51M4.81M-1.96M
Change in Accured Expenses -1.41M2.04M0.25M2.17M2.24M
Other Working Capital Changes 0.77M2.17M-1.36M0.39M-0.09M
Investing Activities
Capital Expenditures 0.32M0.22M1.05M2.28M1.57M
Sales of Property, Plant and Equipment 0.05M
Change in Acquisitions & Divestments 16.00M2.11M
Cash from Investing Activities -0.27M-8.22M4.84M-0.17M-1.57M
Financing Activities
Other financing activities 1.45M0.50M
Cash from Financing Activities 2.05M266.98M-1.45M4.51M114.18M
Additional items
Change in Cash -53.78M177.57M-67.73M-68.97M14.49M
Free Cash Flow -55.92M-81.42M-72.18M-75.58M-99.69M
Net Cash Flow -53.82M177.56M-67.73M-68.97M14.49M